Author :   Lyalkin S.A.

Therapeutic options for breast cancer with low HER2/NEU expression
Authors: Chovgan O.E. Samuseva A.A. Lyalkin S.A. Дата: 2026-01-16
NALIRIFOX protocol as a new standard of care for metastatic pancreatic cancer
Author:Lyalkin S.A. Дата: 2026-01-08
Experience of management of breast cancer in pregnant patient of 28–29 weeks of gestation
Authors: Dronova V.L. Dronov O.I. Lyalkin S.A. Mokryk О.М.... Т. 14, №4 (56)
Features of immune microenvironment in Her2 low breast cancer
Authors: Lyalkin S.A. Krotevich M.S. Smolanka I.I. Shudrak P.A.... Т. 14, №3 (55)
The course features of HER2/neu-low breast cancer
Authors: Bondar M.V. Syvak L.A. Tarasenko T.Ye. Martynyuk O.M.... Т. 13, № 2 (50)